Steward Partners Investment Advisory, LLC - ELEVATION ONCOLOGY INC ownership

ELEVATION ONCOLOGY INC's ticker is ELEV and the CUSIP is 28623U101. A total of 28 filers reported holding ELEVATION ONCOLOGY INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Steward Partners Investment Advisory, LLC ownership history of ELEVATION ONCOLOGY INC
ValueSharesWeighting
Q4 2022$475
-52.5%
5000.0%0.00%
Q3 2022$1,0000.0%5000.0%0.00%
Q2 2022$1,0000.0%5000.0%0.00%
Q1 2022$1,000
-66.7%
5000.0%0.00%
Q4 2021$3,000
-25.0%
5000.0%0.00%
Q3 2021$4,000
-42.9%
5000.0%0.00%
Q2 2021$7,0005000.00%
Other shareholders
ELEVATION ONCOLOGY INC shareholders Q4 2022
NameSharesValueWeighting ↓
Aisling Capital Management LP 2,834,910$7,654,2573.31%
venBio Partners LLC 2,434,255$6,572,4892.84%
Velan Capital Investment Management LP 597,299$1,612,7070.92%
Exome Asset Management LLC 369,322$997,1700.87%
Logos Global Management LP 3,850,000$10,395,0000.84%
TANG CAPITAL MANAGEMENT LLC 3,060,000$8,262,0000.84%
Palo Alto Investors LP 1,800,106$4,860,2860.56%
Darwin Global Management, Ltd. 1,916,290$4,809,8880.56%
Ghost Tree Capital, LLC 600,000$1,620,0000.51%
Affinity Asset Advisors, LLC 1,468,825$3,965,8280.46%
View complete list of ELEVATION ONCOLOGY INC shareholders